aspect of
surgeon)
→
CapableOf
→
receive neoadjuvant chemotherapy
| Typicality: | 0.352 |
| Saliency: | 0.240 |
| for invasive cancer | 3 | purpose |
| at the end of the treatment | 2 | temporal |
| patient → receive → neoadjuvant chemotherapy | 5 |
| patient → be treated with → neoadjuvant chemotherapy | 3 |
| patient → undergo → neoadjuvant chemotherapy | 3 |
| negative | neutral | positive |
| 0.187 | 0.760 | 0.053 |
| Raw frequency | 11 |
| Normalized frequency | 0.240 |
| Modifier score | 0.500 |
| Perplexity | 28.945 |